VERU
VERU clinical trials: VERU INC.
Every trial on ClinicalTrials.gov where VERU INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 12
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
VERU on the catalyst calendar · VERU registry changes
- Primary completion Oct 2027Sponsor estimatePhase 2NCT07446998Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor...Veru Inc. · Obesity & OverweightActive, not recruitingVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 6, 2022ActualPhase 3NCT04842747VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyVeru Inc. · SARS-CoV InfectionCompletedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 11, 2025ActualPhase 2NCT06282458Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtVeru Inc. · Muscle LossCompletedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 19, 2023ActualPhase 3NCT05065411Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerVeru Inc. · Metastatic Breast CancerTerminatedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 4, 2023ActualPhase 3NCT04844749Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentVeru Inc. · Metastatic Castration-resistant Prostate CancerTerminatedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 9, 2024ActualPhase 3NCT04869943Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerVeru Inc. · Metastatic Breast CancerTerminatedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 15, 2023ActualPhase 1/Phase 2NCT03752099To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerVeru Inc. · Metastatic Castration Resistant Prostate CancerTerminatedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 19, 2023ActualPhase 1/Phase 2NCT04843319To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerVeru Inc. · Advanced Prostate AdenocarcinomaTerminatedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2024Sponsor estimatePhase 2NCT05079360Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerVeru Inc. · Metastatic Breast CancerWithdrawnVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2020ActualPhase 2NCT04388826COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111Veru Inc. · Respiratory Distress Syndrome, AdultCompletedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 30, 2022Sponsor estimatePhase 2NCT05008510P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .Veru Inc. · Metastatic Triple Negative Breast CancerWithdrawnVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2020ActualPhase 2NCT03646162Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerVeru Inc. · Prostate Cancer MetastaticCompletedVERULead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner